Anti-p53R2 antibody
5
(2 Reviews)
|
(30 Publications)
Rabbit Polyclonal p53R2 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Mouse, Human, Rat samples. Cited in 30 publications. Immunogen corresponding to Synthetic Peptide within Human RRM2B aa 1-50.
View Alternative Names
P53R2, RRM2B, Ribonucleoside-diphosphate reductase subunit M2 B, TP53-inducible ribonucleotide reductase M2 B, p53-inducible ribonucleotide reductase small subunit 2-like protein, p53R2
- WB
Supplier Data
Western blot - Anti-p53R2 antibody (AB8105)
All lanes:
Western blot - Anti-p53R2 antibody (ab8105) at 1 µg/mL
Lane 1:
3T3 cell lysate with absence of blocking peptide
Lane 2:
3T3 cell lysate with presence of blocking peptide
Predicted band size: 40 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P53R2 plays a role in the synthesis of deoxyribonucleotide triphosphates (dNTPs) for DNA repair. It forms part of a ribonucleotide reductase complex working with other subunits to ensure cells have sufficient dNTP pools for DNA replication and repair. The presence of p53R2 is integral for DNA damage response pathways where it gets activated to supply dNTPs during periods when the p53 tumor suppressor pathway senses DNA damage and activates DNA repair processes.
Pathways
P53R2 is involved in DNA damage response and cell cycle regulation. It interacts with the tumor suppressor protein p53 especially during instances of genotoxic stress facilitating DNA repair and cell cycle arrest to prevent propagation of damaged DNA. Additionally p53R2 relates to proteins such as p21 which are components of the p53 pathway influencing cell cycle arrest and allowing time for DNA repair before cell division resumes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (30)
Recent publications for all applications. Explore the full list and refine your search
Nucleic acids research 52:12351-12377 PubMed39315696
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed37444452
2023
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 12:e10419 PubMed31950591
2020
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 12:8367-8378 PubMed31632084
2019
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 9:956 PubMed31637211
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 10:3505-3511 PubMed30271199
2018
Applications
Unspecified application
Species
Unspecified reactive species
Nature chemical biology 14:943-954 PubMed30150681
2018
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 17:855 PubMed29246119
2017
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:101572-101590 PubMed29254187
2017
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 16:1673-1682 PubMed28841361
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com